| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin filament binding | 4.39e-05 | 227 | 181 | 10 | GO:0051015 | |
| GeneOntologyMolecularFunction | phosphotyrosine residue binding | 9.70e-05 | 51 | 181 | 5 | GO:0001784 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | DSG2 DSP OBSCN EXOC3 ITGAL GSK3B PTPN6 DST PTPRJ CTNNA2 BZW1 PLEC EPCAM FRMD5 CDH17 | 3.80e-04 | 599 | 181 | 15 | GO:0050839 |
| GeneOntologyMolecularFunction | protein phosphorylated amino acid binding | 4.07e-04 | 69 | 181 | 5 | GO:0045309 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | NRAP KIF27 VEZT MYO7A MYO9A CFL1 CFL2 SPTA1 OBSCN GABARAPL2 NEB DYSF TUBGCP5 ARPC3 GSK3B TBCB DST MYLIP KCNQ2 CTNNA2 PLEC FRMD5 | 4.09e-04 | 1099 | 181 | 22 | GO:0008092 |
| GeneOntologyBiologicalProcess | response to interleukin-3 | 2.34e-05 | 7 | 183 | 3 | GO:0036015 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-3 | 2.34e-05 | 7 | 183 | 3 | GO:0036016 | |
| GeneOntologyCellularComponent | cell cortex | FLOT2 MYO7A CFL1 SPTA1 EXOC3 ITPR2 TBCB DST GUCY1B1 GPSM2 ASTN2 CTNNA2 EXOC2 NLRP4 | 4.60e-06 | 371 | 181 | 14 | GO:0005938 |
| GeneOntologyCellularComponent | cell-cell junction | FLOT2 NRAP DSG2 VEZT DSP CFL1 OBSCN ITGAL PTPN6 DST PTPRJ ABI2 CTNNA2 ABCC2 EPCAM FRMD5 CDH17 | 1.59e-05 | 591 | 181 | 17 | GO:0005911 |
| GeneOntologyCellularComponent | secretory vesicle | DOCK2 FLOT2 DMXL2 ATP8B4 VEZT DSP WFS1 SRI EXOC3 LCN2 ITGAL DYSF F5 DNAJB3 ITPR2 CCT6A MYOF PTPN6 ATP11B AP2A1 PTPRJ UBE3A SLC6A5 C3 ATM KNG1 | 2.78e-05 | 1246 | 181 | 26 | GO:0099503 |
| GeneOntologyCellularComponent | Z disc | 5.24e-05 | 151 | 181 | 8 | GO:0030018 | |
| GeneOntologyCellularComponent | secretory granule | DOCK2 FLOT2 DMXL2 ATP8B4 VEZT DSP WFS1 SRI EXOC3 LCN2 ITGAL F5 DNAJB3 ITPR2 CCT6A PTPN6 ATP11B AP2A1 PTPRJ SLC6A5 C3 KNG1 | 6.91e-05 | 1014 | 181 | 22 | GO:0030141 |
| GeneOntologyCellularComponent | I band | 1.02e-04 | 166 | 181 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | anchoring junction | FLOT2 NRAP DSG2 VEZT DSP CFL1 OBSCN ITGAL ARPC3 JAK1 JAK2 PTPN6 DST PTPRJ ABI2 CTNNA2 PLEC ABCC2 EPCAM FRMD5 CDH17 | 1.15e-04 | 976 | 181 | 21 | GO:0070161 |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.68e-04 | 94 | 181 | 6 | GO:0044291 | |
| GeneOntologyCellularComponent | intercalated disc | 3.09e-04 | 68 | 181 | 5 | GO:0014704 | |
| GeneOntologyCellularComponent | sarcomere | 3.32e-04 | 249 | 181 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | striated muscle myosin thick filament | 4.42e-04 | 4 | 181 | 2 | GO:0005863 | |
| GeneOntologyCellularComponent | myofibril | 6.46e-04 | 273 | 181 | 9 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 9.89e-04 | 290 | 181 | 9 | GO:0043292 | |
| Domain | SH2 | 1.13e-05 | 110 | 180 | 8 | SM00252 | |
| Domain | SH2 | 1.21e-05 | 111 | 180 | 8 | PS50001 | |
| Domain | SH2 | 1.29e-05 | 112 | 180 | 8 | IPR000980 | |
| Domain | - | 1.29e-05 | 112 | 180 | 8 | 3.30.505.10 | |
| Domain | PH_dom-like | PHLDB3 PSD2 MYO7A NBEAL1 SH3BP2 OBSCN DOCK10 DGKD STAP1 JAK1 JAK2 ELMO3 MYLIP PLCG2 FRMD5 | 1.69e-05 | 426 | 180 | 15 | IPR011993 |
| Domain | - | 1.72e-05 | 6 | 180 | 3 | 3.90.1290.10 | |
| Domain | Plectin | 2.99e-05 | 7 | 180 | 3 | PF00681 | |
| Domain | Plectin_repeat | 2.99e-05 | 7 | 180 | 3 | IPR001101 | |
| Domain | PLEC | 2.99e-05 | 7 | 180 | 3 | SM00250 | |
| Domain | SH2 | 5.51e-05 | 101 | 180 | 7 | PF00017 | |
| Domain | DnaJ | 9.63e-05 | 48 | 180 | 5 | PF00226 | |
| Domain | DNAJ_1 | 1.06e-04 | 49 | 180 | 5 | PS00636 | |
| Domain | DNAJ_2 | 1.06e-04 | 49 | 180 | 5 | PS50076 | |
| Domain | FERM_central | 1.06e-04 | 49 | 180 | 5 | IPR019748 | |
| Domain | FERM_domain | 1.06e-04 | 49 | 180 | 5 | IPR000299 | |
| Domain | DnaJ | 1.06e-04 | 49 | 180 | 5 | SM00271 | |
| Domain | - | 1.06e-04 | 49 | 180 | 5 | 1.10.287.110 | |
| Domain | FERM_1 | 1.17e-04 | 50 | 180 | 5 | PS00660 | |
| Domain | FERM_2 | 1.17e-04 | 50 | 180 | 5 | PS00661 | |
| Domain | FERM_3 | 1.17e-04 | 50 | 180 | 5 | PS50057 | |
| Domain | Band_41_domain | 1.17e-04 | 50 | 180 | 5 | IPR019749 | |
| Domain | B41 | 1.17e-04 | 50 | 180 | 5 | SM00295 | |
| Domain | DnaJ_domain | 1.29e-04 | 51 | 180 | 5 | IPR001623 | |
| Domain | Spectrin_repeat | 1.64e-04 | 29 | 180 | 4 | IPR002017 | |
| Domain | SPEC | 2.43e-04 | 32 | 180 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.43e-04 | 32 | 180 | 4 | IPR018159 | |
| Domain | FerA | 2.75e-04 | 3 | 180 | 2 | SM01200 | |
| Domain | Ferlin_A-domain | 2.75e-04 | 3 | 180 | 2 | IPR012560 | |
| Domain | FerA | 2.75e-04 | 3 | 180 | 2 | PF08165 | |
| Domain | ADF/Cofilin | 2.75e-04 | 3 | 180 | 2 | IPR017904 | |
| Domain | SH3_domain | 2.91e-04 | 220 | 180 | 9 | IPR001452 | |
| Domain | - | PHLDB3 PSD2 MYO7A SH3BP2 OBSCN DOCK10 DGKD STAP1 ELMO3 MYLIP PLCG2 FRMD5 | 4.24e-04 | 391 | 180 | 12 | 2.30.29.30 |
| Domain | Nebulin | 5.47e-04 | 4 | 180 | 2 | PF00880 | |
| Domain | NEBULIN | 5.47e-04 | 4 | 180 | 2 | PS51216 | |
| Domain | NEBU | 5.47e-04 | 4 | 180 | 2 | SM00227 | |
| Domain | DysFC | 5.47e-04 | 4 | 180 | 2 | SM00694 | |
| Domain | DysFN | 5.47e-04 | 4 | 180 | 2 | SM00693 | |
| Domain | Nebulin | 5.47e-04 | 4 | 180 | 2 | IPR013998 | |
| Domain | Nebulin_repeat | 5.47e-04 | 4 | 180 | 2 | IPR000900 | |
| Domain | Tyr_kinase_non-rcpt_Jak/Tyk2 | 5.47e-04 | 4 | 180 | 2 | IPR016251 | |
| Domain | Peroxin/Ferlin | 5.47e-04 | 4 | 180 | 2 | IPR006614 | |
| Domain | FerI | 9.06e-04 | 5 | 180 | 2 | SM01202 | |
| Domain | FerB | 9.06e-04 | 5 | 180 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 9.06e-04 | 5 | 180 | 2 | IPR012561 | |
| Domain | Ferlin_C | 9.06e-04 | 5 | 180 | 2 | PF16165 | |
| Domain | Ferlin_C | 9.06e-04 | 5 | 180 | 2 | IPR032362 | |
| Domain | FerIin_dom | 9.06e-04 | 5 | 180 | 2 | IPR012968 | |
| Domain | FerI | 9.06e-04 | 5 | 180 | 2 | PF08151 | |
| Domain | FerB | 9.06e-04 | 5 | 180 | 2 | PF08150 | |
| Domain | Cu-oxidase_3 | 9.06e-04 | 5 | 180 | 2 | IPR011707 | |
| Domain | MULTICOPPER_OXIDASE1 | 9.06e-04 | 5 | 180 | 2 | PS00079 | |
| Domain | Cu_oxidase_CS | 9.06e-04 | 5 | 180 | 2 | IPR033138 | |
| Domain | Cu-oxidase_3 | 9.06e-04 | 5 | 180 | 2 | PF07732 | |
| Domain | IQ | 1.12e-03 | 81 | 180 | 5 | SM00015 | |
| Domain | SH3 | 1.20e-03 | 216 | 180 | 8 | PS50002 | |
| Domain | Cu_oxidase_Cu_BS | 1.35e-03 | 6 | 180 | 2 | IPR002355 | |
| Domain | Ribosomal_S6_kinase_II | 1.35e-03 | 6 | 180 | 2 | IPR016239 | |
| Domain | PH | 1.54e-03 | 278 | 180 | 9 | SM00233 | |
| Domain | PH_DOMAIN | 1.58e-03 | 279 | 180 | 9 | PS50003 | |
| Domain | PH_domain | 1.62e-03 | 280 | 180 | 9 | IPR001849 | |
| Domain | PH | 1.74e-03 | 229 | 180 | 8 | PF00169 | |
| Domain | IQ_motif_EF-hand-BS | 1.78e-03 | 90 | 180 | 5 | IPR000048 | |
| Domain | IQ | 2.06e-03 | 93 | 180 | 5 | PS50096 | |
| Domain | HECT | 2.17e-03 | 27 | 180 | 3 | PF00632 | |
| Domain | HECTc | 2.17e-03 | 27 | 180 | 3 | SM00119 | |
| Domain | HECT_dom | 2.17e-03 | 27 | 180 | 3 | IPR000569 | |
| Domain | DnaJ_domain_CS | 2.17e-03 | 27 | 180 | 3 | IPR018253 | |
| Domain | HECT | 2.17e-03 | 27 | 180 | 3 | PS50237 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 2.47e-05 | 36 | 138 | 5 | M1315 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DOCK2 FLOT2 DSG2 DSP MYO9A PIK3R3 PAK5 GPS1 OBSCN DOCK10 CPD ARHGAP5 CCT6A DST ABI2 | 2.59e-05 | 439 | 138 | 15 | MM15595 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DOCK2 FLOT2 DSG2 DSP MYO9A PIK3R3 PAK5 GPS1 OBSCN DOCK10 CPD ARHGAP5 CCT6A DST ABI2 | 3.45e-05 | 450 | 138 | 15 | M27078 |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 5.32e-05 | 42 | 138 | 5 | M41826 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 5.32e-05 | 42 | 138 | 5 | M41828 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 5.32e-05 | 42 | 138 | 5 | MM15677 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 5.97e-05 | 43 | 138 | 5 | MM15679 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 9.63e-05 | 188 | 138 | 9 | MM15828 | |
| Pathway | REACTOME_HEMOSTASIS | DOCK2 PDE1A KIF27 CFL1 PIK3R3 SRI DOCK10 DGKD APOB ITGAL F5 ITPR2 JAK2 PTPN6 GUCY1B1 PLCG2 EPCAM KNG1 | 1.11e-04 | 679 | 138 | 18 | M8395 |
| Pathway | REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING | 1.30e-04 | 27 | 138 | 4 | M921 | |
| Pathway | REACTOME_HEMOSTASIS | DOCK2 PDE1A KIF27 PIK3R3 SRI DOCK10 DGKD APOB ITGAL F5 ITPR2 JAK2 PTPN6 PLCG2 EPCAM KNG1 | 1.46e-04 | 571 | 138 | 16 | MM14472 |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.95e-04 | 86 | 138 | 6 | M916 | |
| Pathway | PID_P53_REGULATION_PATHWAY | 2.74e-04 | 59 | 138 | 5 | M261 | |
| Pathway | REACTOME_REGULATION_OF_IFNG_SIGNALING | 3.09e-04 | 14 | 138 | 3 | M942 | |
| Pathway | WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY | 3.15e-04 | 132 | 138 | 7 | M39338 | |
| Pathway | KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS | 3.55e-04 | 96 | 138 | 6 | M16121 | |
| Pubmed | DMXL2 ATRX DSP SRI DARS1 TUBGCP5 DCAF5 YARS1 EEF1A2 JAK1 ARHGAP5 SETDB1 MAN1A2 DST MIA2 AP2A1 GUCY1B1 UBE3A CTR9 KCNQ2 GPSM2 ASTN2 ATM EIF3D GFPT2 PLEC DNAJB2 AFF4 | 2.57e-10 | 1285 | 185 | 28 | 35914814 | |
| Pubmed | FLOT2 DMXL2 MYO7A DSP MYO9A WFS1 CFL1 CFL2 SPTA1 DNAJB6 DARS1 GABARAPL2 ARPC3 GSK3B YARS1 EEF1A2 ITPR2 ARHGAP5 CCT6A DST AP2A1 FAM120C XRN1 PLXNA4 KCNQ2 CTNNA2 PLEC TRAPPC9 KNG1 | 6.33e-10 | 1431 | 185 | 29 | 37142655 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ZNF148 VEZT WFS1 SLC26A2 SQLE PSMC4 GABARAPL2 CPD APOB ERGIC2 EEF1A2 TBCB JAK1 JAK2 MYOF TM9SF2 AP2A1 PTPRJ ATM CTNNA2 DNAJB2 EPCAM CDH17 ALG13 | 2.69e-09 | 1061 | 185 | 24 | 33845483 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | PHLDB3 IRF2BP1 ATRX MYO7A UBE3B GPS1 VPS50 PSMC4 EXOC3 LCN2 ARPC3 PGM3 CLASRP SETDB1 TM9SF2 AP2A1 CTR9 C3 EIF3D BZW1 EXOC2 PLEC TRAPPC9 TP53BP1 CCDC144A HSP90AB3P | 9.75e-09 | 1321 | 185 | 26 | 27173435 |
| Pubmed | DOCK2 FLOT2 GNL3L CFL1 VPS50 DNAJB6 DOCK10 PSMC4 DARS1 CPD ERGIC2 ITGAL F5 ARPC3 ITPR2 MAN1A2 MIA2 ATP11B AP2A1 XRN1 PRKAG1 EIF3D BZW1 EXOC2 | 1.70e-08 | 1168 | 185 | 24 | 19946888 | |
| Pubmed | ZNF484 IRF2BP1 ATRX SRI ASH2L ARHGAP5 SETDB1 PBRM1 MAN1A2 DST TM9SF2 AP2A1 UBE3A CTR9 PLCG2 PLEC DNAJB2 | 2.15e-08 | 591 | 185 | 17 | 15231748 | |
| Pubmed | FLOT2 DSG2 DSP CFL1 SRI PSMC4 GABARAPL2 CPD APOB ERGIC2 GSK3B YARS1 JAK1 CCT6A MYOF DST TM9SF2 AP2A1 PDIA5 C3 ECEL1 CTNNA2 BZW1 SEC63 TP53BP1 | 2.90e-08 | 1297 | 185 | 25 | 33545068 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | ATRX CFL2 RPS6KA2 RPS6KA3 PAK5 GSK3B CCNA2 ITPR2 JAK1 JAK2 MYOF DST AP2A1 CTR9 PRKAG1 MLLT1 PDIA5 EIF3D PLEC AFF4 | 9.92e-08 | 910 | 185 | 20 | 36736316 |
| Pubmed | FLOT2 ZNF148 KAT5 IRF2BP1 ATRX PSMC4 DARS1 ARPC3 ASH2L DCAF5 CCNA2 PRR12 FHAD1 CCT6A SETDB1 RBM12 PBRM1 DST XRN1 SUGP1 MLLT1 EIF3D GFPT2 TRAPPC9 TP53BP1 | 1.83e-07 | 1429 | 185 | 25 | 35140242 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 2.19e-07 | 211 | 185 | 10 | 24097068 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | ATRX RPS6KA3 PSMC4 DARS1 EEF1A2 CCT6A SETDB1 PBRM1 CTR9 BZW1 PLEC TP53BP1 | 2.51e-07 | 332 | 185 | 12 | 32786267 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PHLDB3 GNL3L DSP MYO9A CFL1 DNAJB6 DOCK10 PSMC4 EXOC3 DGKD DARS1 GSK3B TBCB CCT6A DST AP2A1 UBE3A CTR9 XRN1 EIF3D PLCG2 EXOC2 PLEC TP53BP1 | 2.57e-07 | 1353 | 185 | 24 | 29467282 |
| Pubmed | PCSK5 DMXL2 GNL3L ATRX UBE3B DOCK10 EXOC3 COLGALT2 ERGIC2 FHIP2A ASH2L PRR12 FREM2 DST CTR9 XRN1 | 4.61e-07 | 650 | 185 | 16 | 38777146 | |
| Pubmed | DMXL2 NRAP MYOM1 DSP OBSCN DNAJB6 DGKD NEB DYSF ASH2L CCT6A DST MED12L PLEC | 5.08e-07 | 497 | 185 | 14 | 23414517 | |
| Pubmed | FLOT2 GNL3L ZNF148 KAT5 DSG2 VEZT SH3BP2 PIK3R3 VPS50 DNAJB6 TUBGCP5 DCAF5 JAK1 SETDB1 MLH3 PBRM1 FAM120C XRN1 MLLT1 AFF4 ALG13 | 5.99e-07 | 1116 | 185 | 21 | 31753913 | |
| Pubmed | FLOT2 DMXL2 VEZT DSP WFS1 PSMC4 DARS1 ZDBF2 YARS1 TBCB CCT6A GUCY1B1 ABI2 UBE3A FAM120C XRN1 KCNQ2 CTNNA2 PLEC DNAJB2 TP53BP1 | 8.30e-07 | 1139 | 185 | 21 | 36417873 | |
| Pubmed | GNL3L KAT5 ATRX DSG2 ARPC3 ASH2L TMX2 PRR12 CCT6A MYOF PBRM1 MAN1A2 DST ABI2 FAM120C ZBED6 CTR9 XRN1 MLLT1 EIF3D CTNNA2 EXOC2 SEC63 AFF4 | 1.54e-06 | 1497 | 185 | 24 | 31527615 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYO7A DSP OBSCN ESCO1 EEF1A2 ITPR2 JAK2 ARHGAP5 FREM2 LOXHD1 DST FAM120C PLXNA4 MLLT1 ATM EIF3D | 2.32e-06 | 736 | 185 | 16 | 29676528 |
| Pubmed | ATRX DSP CFL1 CFL2 SPTA1 GPS1 DNAJB6 APOB NEB DNAJB3 EEF1A2 TBCB CCT6A DST MIA2 AP2A1 CTR9 XRN1 PLXNA4 MLLT1 ATM PLEC ABCC2 | 2.82e-06 | 1442 | 185 | 23 | 35575683 | |
| Pubmed | 2.93e-06 | 6 | 185 | 3 | 14978237 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | GNL3L MYO7A GPS1 VPS50 OBSCN PSMC4 EXOC3 AK9 NEB DYSF LOXHD1 ATM HYDIN | 2.96e-06 | 497 | 185 | 13 | 36774506 |
| Pubmed | FLOT2 DMXL2 ZNF148 ATRX DSG2 VEZT WFS1 DNAJC25 PIK3R3 DNAJB6 PSMC4 EXOC3 CPD DNAJB3 DCAF5 EEF1A2 ITPR2 CTR9 PDIA5 ATM SEC63 DNAJB2 TP53BP1 | 4.68e-06 | 1487 | 185 | 23 | 33957083 | |
| Pubmed | Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK. | 5.10e-06 | 7 | 185 | 3 | 9178903 | |
| Pubmed | FLOT2 DSG2 DSP MYO9A CFL1 DNAJB6 PSMC4 EXOC3 DARS1 CPD CCT6A DST XRN1 BZW1 SEC63 | 6.59e-06 | 708 | 185 | 15 | 39231216 | |
| Pubmed | 6.89e-06 | 131 | 185 | 7 | 28031328 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | DOCK2 DSP CFL1 SPTA1 PSMC4 DARS1 ARPC3 EEF1A2 CCT6A MYOF DST AP2A1 BZW1 PLEC HYDIN ALG13 | 7.39e-06 | 807 | 185 | 16 | 30575818 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCSK5 PHLDB3 MYO7A CFL1 RPS6KA2 UBE3B OBSCN DYSF ITPR2 JAK2 PRR12 MYOF DST AP2A1 KCNQ2 MLLT1 PDIA5 PLEC TRAPPC9 | 7.73e-06 | 1105 | 185 | 19 | 35748872 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLOT2 ATP8B4 GNL3L KIF27 ATRX DSG2 DSP CFL1 PSMC4 DARS1 APOB YARS1 CCT6A PBRM1 TM9SF2 AP2A1 CTR9 ATM EIF3D BZW1 SEC63 MGAM2 | 7.89e-06 | 1425 | 185 | 22 | 30948266 |
| Pubmed | ATRX SLC26A2 SQLE ZDBF2 TUBGCP5 ASH2L PGM3 CCNA2 TBCB CCT6A PBRM1 UBE3A CTR9 MYLIP XRN1 SUGP1 PRKAG1 ECEL1 BZW1 SNAPC2 SEC63 | 8.89e-06 | 1327 | 185 | 21 | 32694731 | |
| Pubmed | A quantitative protein interaction network for the ErbB receptors using protein microarrays. | 8.98e-06 | 90 | 185 | 6 | 16273093 | |
| Pubmed | FLOT2 GNL3L IRF2BP1 CFL2 RPS6KA3 DNAJB6 PSMC4 FHIP2A ARPC3 PGM3 CCNA2 ITPR2 CCT6A MYOF DST ATM EIF3D CTNNA2 BZW1 EXOC2 SEC63 TRAPPC9 | 9.28e-06 | 1440 | 185 | 22 | 30833792 | |
| Pubmed | 9.75e-06 | 322 | 185 | 10 | 26514267 | ||
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | RPS6KA3 PIK3R3 DNAJB6 APOB PKDREJ EEF1A2 AP2A1 CTNNA2 DNAJB2 | 1.03e-05 | 256 | 185 | 9 | 24189400 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | FLOT2 GNL3L ZNF148 ATRX DSG2 DSP CFL1 DARS1 EEF1A2 TBCB RBM12 DST XRN1 SUGP1 EIF3D AFF4 TP53BP1 | 1.15e-05 | 934 | 185 | 17 | 33916271 |
| Pubmed | P90 Ribosomal s6 kinase 2 negatively regulates axon growth in motoneurons. | 1.21e-05 | 9 | 185 | 3 | 19555761 | |
| Pubmed | 1.21e-05 | 9 | 185 | 3 | 12482924 | ||
| Pubmed | PDE1A DSG2 VEZT DSP NBEAL1 ZDBF2 EEF1A2 TBCB DST XRN1 BZW1 SEC63 ALG13 | 1.24e-05 | 568 | 185 | 13 | 37774976 | |
| Pubmed | 1.24e-05 | 56 | 185 | 5 | 37059927 | ||
| Pubmed | FLOT2 DSG2 CFL2 DNAJB6 PSMC4 F5 ARPC3 MYOF DST AP2A1 CTR9 CSNK1G1 EIF3D PLEC | 1.33e-05 | 660 | 185 | 14 | 32780723 | |
| Pubmed | 1.34e-05 | 334 | 185 | 10 | 30425250 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FLOT2 GNL3L DSG2 DSP CFL1 CFL2 DNAJB6 DARS1 F5 ARPC3 YARS1 ITPR2 CCT6A MYOF DST AP2A1 C3 EIF3D PLEC SEC63 | 1.36e-05 | 1257 | 185 | 20 | 36526897 |
| Pubmed | GNL3L DSG2 DSP WFS1 CFL1 RPS6KA3 PSMC4 DARS1 APOB EEF1A2 ARHGAP5 PBRM1 FAM111A AP2A1 FAM120C CSNK1G1 PDIA5 CTNNA2 PLEC SEC63 AFF4 | 1.45e-05 | 1371 | 185 | 21 | 36244648 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 1.48e-05 | 268 | 185 | 9 | 33024031 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KBTBD3 GNL3L ATRX VEZT MYO9A RPS6KA2 SH3BP2 PIK3R3 OBSCN CPD ESCO1 EEF1A2 JAK2 FAM111A ATP11B PTPRJ FAM120C PRKAG1 PDIA5 ASTN2 TRAPPC9 AFF4 | 1.56e-05 | 1489 | 185 | 22 | 28611215 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DOCK2 KIF27 ATRX DSP PSMC4 CCT6A FAM120C MED12L PRKAG1 ATM BZW1 EXOC2 PLEC | 1.60e-05 | 582 | 185 | 13 | 20467437 |
| Pubmed | Apocrine glands are bystanders in hidradenitis suppurativa and their involvement is gender specific. | 1.60e-05 | 59 | 185 | 5 | 32031713 | |
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | TRPA1 WFS1 PSMC4 APOB CCNA2 JAK1 CCT6A MYOF TM9SF2 AP2A1 UBE3A SEC63 | 1.66e-05 | 499 | 185 | 12 | 22810586 |
| Pubmed | DMXL2 CFL1 RPS6KA2 PAK5 ARPC3 GSK3B EEF1A2 PBRM1 DST AP2A1 ABI2 UBE3A FAM120C KCNJ4 CTNNA2 AFF4 TP53BP1 | 1.71e-05 | 963 | 185 | 17 | 28671696 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 1.72e-05 | 344 | 185 | 10 | 30333137 | |
| Pubmed | The hot-spot p53R172H mutant promotes formation of giant spermatogonia triggered by DNA damage. | 1.73e-05 | 10 | 185 | 3 | 27869164 | |
| Pubmed | 1.74e-05 | 60 | 185 | 5 | 20682791 | ||
| Pubmed | 1.74e-05 | 101 | 185 | 6 | 10997877 | ||
| Pubmed | PHLDB3 FLOT2 DSG2 PIK3R3 EXOC3 CPD ARHGAP5 DST AP2A1 ABI2 SEC63 | 1.76e-05 | 421 | 185 | 11 | 36976175 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ATRX DSP MYO9A VPS50 PSMC4 EXOC3 ZDBF2 GSK3B YARS1 SETDB1 CTR9 ZMYM6 TP53BP1 | 1.78e-05 | 588 | 185 | 13 | 38580884 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | FLOT2 SLC26A2 CFL1 CFL2 SRI APOB LCN2 DYSF OGN ARPC3 CFHR3 CCT6A FREM2 MYOF PTPRJ C3 KNG1 HSP90AB3P | 1.82e-05 | 1070 | 185 | 18 | 23533145 |
| Pubmed | ZNF148 DSG2 GPS1 LCN2 NEB TUBGCP5 CCNA2 ITPR2 DST CTR9 SERTAD4 C3 PLCG2 SNAPC2 PLEC EPCAM SLC38A6 HYDIN TP53BP1 ALG13 | 2.04e-05 | 1293 | 185 | 20 | 15342556 | |
| Pubmed | OGFRL1 SCRN3 ATRX RPS6KA3 OBSCN APOB ASH2L DCAF5 E2F8 ARHGAP5 AREL1 CTR9 GFPT2 PLEC SEC63 NLRP4 AFF4 TP53BP1 | 2.15e-05 | 1084 | 185 | 18 | 11544199 | |
| Pubmed | 2.21e-05 | 63 | 185 | 5 | 11572484 | ||
| Pubmed | 2.37e-05 | 11 | 185 | 3 | 12802069 | ||
| Pubmed | 2.69e-05 | 222 | 185 | 8 | 37071664 | ||
| Pubmed | ATM and 53BP1 regulate alternative end joining-mediated V(D)J recombination. | 2.81e-05 | 2 | 185 | 2 | 39083600 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 28645562 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 22087308 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 22898789 | ||
| Pubmed | A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. | 2.81e-05 | 2 | 185 | 2 | 16141325 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 23858098 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 9111009 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 24158701 | ||
| Pubmed | SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation. | 2.81e-05 | 2 | 185 | 2 | 33827897 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 29378238 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 27614023 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 23761909 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 29508247 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 8943354 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 27222478 | ||
| Pubmed | Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations. | 2.81e-05 | 2 | 185 | 2 | 27903500 | |
| Pubmed | Two members of the JAK family of protein tyrosine kinases map to chromosomes 1p31.3 and 9p24. | 2.81e-05 | 2 | 185 | 2 | 1581631 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 19887489 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 18243662 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 12565881 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 27461052 | ||
| Pubmed | Tyrosine kinase pathways modulate tumor susceptibility to natural killer cells. | 2.81e-05 | 2 | 185 | 2 | 22684105 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 18495154 | ||
| Pubmed | ATM and KAT5 safeguard replicating chromatin against formaldehyde damage. | 2.81e-05 | 2 | 185 | 2 | 26420831 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 11495723 | ||
| Pubmed | The ADF/cofilin proteins: stimulus-responsive modulators of actin dynamics. | 2.81e-05 | 2 | 185 | 2 | 8589446 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 24055036 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 1848670 | ||
| Pubmed | AMPK Complex Activation Promotes Sarcolemmal Repair in Dysferlinopathy. | 2.81e-05 | 2 | 185 | 2 | 32087766 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 33811972 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 29263442 | ||
| Pubmed | Structure of msj-1 gene in mice and humans: a possible role in the regulation of male reproduction. | 2.81e-05 | 2 | 185 | 2 | 18184612 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 8636158 | ||
| Pubmed | Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy. | 2.81e-05 | 2 | 185 | 2 | 27170944 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 24023293 | ||
| Pubmed | Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains. | 2.81e-05 | 2 | 185 | 2 | 11959863 | |
| Pubmed | 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells. | 2.81e-05 | 2 | 185 | 2 | 27613518 | |
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 34354129 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 8800436 | ||
| Pubmed | 2.81e-05 | 2 | 185 | 2 | 24169825 | ||
| Interaction | TRIM66 interactions | FLOT2 GNL3L DSG2 VEZT PIK3R3 VPS50 TUBGCP5 JAK1 MLH3 FAM120C ALG13 | 3.01e-06 | 205 | 184 | 11 | int:TRIM66 |
| Interaction | FGFR1 interactions | FLOT2 DSG2 VEZT CFL1 RPS6KA2 SH3BP2 RPS6KA3 OBSCN CPD JAK2 AP2A1 ABI2 SEL1L2 PLCG2 PLEC SEC63 EPCAM TRAPPC9 HSP90AB3P | 5.61e-06 | 632 | 184 | 19 | int:FGFR1 |
| Interaction | KCTD13 interactions | FLOT2 DMXL2 MYO7A DSP MYO9A WFS1 CFL1 CFL2 SPTA1 DNAJB6 DARS1 GABARAPL2 ARPC3 GSK3B YARS1 EEF1A2 ITPR2 ARHGAP5 CCT6A DST AP2A1 FAM120C XRN1 PLXNA4 KCNQ2 CTNNA2 GFPT2 PLEC TRAPPC9 KNG1 | 9.63e-06 | 1394 | 184 | 30 | int:KCTD13 |
| Interaction | AR interactions | FLOT2 ZNF148 KAT5 ATRX DSG2 DSP PIK3R3 PSMC4 ASH2L STAP1 GSK3B PRR12 CCT6A MLH3 RBM12 PBRM1 UBE3A CTR9 MYLIP SUGP1 MED12L PRKAG1 PLCG2 AFF4 | 1.28e-05 | 992 | 184 | 24 | int:AR |
| Interaction | ISG15 interactions | FLOT2 DSG2 CFL1 DNAJB6 PSMC4 DARS1 IFIT2 EEF1A2 JAK1 CCT6A MYOF TM9SF2 AP2A1 FAM120C PLEC DNAJB2 | 1.28e-05 | 494 | 184 | 16 | int:ISG15 |
| Interaction | LCK interactions | PHLDB3 FLOT2 DSG2 DSP SH3BP2 EXOC3 STAP1 YARS1 CCT6A PTPN6 DST AP2A1 UBE3A PLCG2 HSP90AB3P | 2.41e-05 | 463 | 184 | 15 | int:LCK |
| GeneFamily | SH2 domain containing | 6.75e-06 | 101 | 126 | 7 | 741 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.80e-05 | 8 | 126 | 3 | 939 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 2.26e-05 | 49 | 126 | 5 | 584 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.50e-05 | 50 | 126 | 5 | 1293 | |
| GeneFamily | Ferlin family | 7.10e-04 | 6 | 126 | 2 | 828 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.68e-03 | 9 | 126 | 2 | 1280 | |
| GeneFamily | Exocyst complex | 1.68e-03 | 9 | 126 | 2 | 1055 | |
| GeneFamily | Tudor domain containing | 2.16e-03 | 37 | 126 | 3 | 780 | |
| GeneFamily | Mitogen-activated protein kinase-activated protein kinases | 2.54e-03 | 11 | 126 | 2 | 1156 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DOCK2 FLOT2 ZNF148 ATRX MYO7A SLC26A2 CFL1 RPS6KA3 DNAJB6 DOCK10 DARS1 ITGAL FHIP2A IL18R1 ARPC3 DCAF5 ITPR2 TBCB JAK1 PTPN6 RBM12 MAN1A2 FAM111A ATP11B PTPRJ UBE3A MYLIP XRN1 ATM BZW1 | 2.09e-07 | 1492 | 185 | 30 | M40023 |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP | ATP8B4 PSD2 DOCK10 COLGALT2 IL18R1 ANGPTL1 TM9SF2 PTPRJ PLCG2 CLNK | 2.32e-07 | 161 | 185 | 10 | M9446 |
| Coexpression | GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN | OGFRL1 ATRX CFL1 RPS6KA3 IL18R1 SETDB1 MYOF ATP11B UBE3A SEC63 | 1.70e-06 | 200 | 185 | 10 | M4878 |
| Coexpression | HALLMARK_PI3K_AKT_MTOR_SIGNALING | 9.90e-06 | 105 | 185 | 7 | M5923 | |
| Coexpression | GRUETZMANN_PANCREATIC_CANCER_UP | DOCK2 FLOT2 PDE1A SPTA1 SRI DGKD LCN2 CCNA2 TBCB PLCG2 BZW1 PLEC | 1.02e-05 | 359 | 185 | 12 | M15193 |
| Coexpression | GSE3982_DC_VS_TH2_DN | 1.27e-05 | 199 | 185 | 9 | M5486 | |
| Coexpression | GSE22886_CD8_VS_CD4_NAIVE_TCELL_UP | SLC26A2 RPS6KA3 DARS1 GABARAPL2 ERGIC2 IL18R1 AREL1 EXOC2 ZMYM6 | 1.32e-05 | 200 | 185 | 9 | M4402 |
| Coexpression | NEWMAN_ERCC6_TARGETS_UP | 3.18e-05 | 26 | 185 | 4 | M5459 | |
| Coexpression | GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_UP | 3.60e-05 | 175 | 185 | 8 | M8578 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | OGFRL1 ATRX DSG2 VPS50 IFIT2 GSK3B YARS1 PGM3 ARHGAP5 CCT6A ATP11B XRN1 BZW1 PLEC FRMD5 AFF4 | 5.66e-05 | 721 | 185 | 16 | M10237 |
| Coexpression | GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_DN | 8.27e-05 | 146 | 185 | 7 | M6341 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP | 9.22e-05 | 200 | 185 | 8 | M4626 | |
| Coexpression | GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_UP | 9.22e-05 | 200 | 185 | 8 | M8322 | |
| Coexpression | GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_DN | 9.22e-05 | 200 | 185 | 8 | M9957 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | OGFRL1 SCRN3 ATRX CFL2 RPS6KA3 ERGIC2 IFIT2 ESCO1 DCAF5 ARHGAP5 PBRM1 ABI2 BZW1 | 9.41e-05 | 523 | 185 | 13 | M12707 |
| Coexpression | LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX | 1.06e-04 | 152 | 185 | 7 | M39239 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | DMXL2 KIF27 DSP MYO9A PIK3R3 VPS50 DNAJB6 DGKD DARS1 ESCO1 SETDB1 ATP11B SUGP1 MED12L GPSM2 ATM PLCG2 EPCAM NLRP4 ZMYM6 ALG13 | 7.88e-06 | 820 | 182 | 21 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | PDE1A DSG2 PAK5 DOCK10 STAP1 ITPR2 PTPRJ GPSM2 ATP6V1C2 PLCG2 CLNK | 1.89e-10 | 174 | 185 | 11 | 5f4436863a40f8bca46e2989bca66c02b6be88d4 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | PDE1A DSG2 PAK5 DOCK10 STAP1 ITPR2 LOXHD1 PTPRJ ATP6V1C2 PLCG2 CLNK | 2.01e-10 | 175 | 185 | 11 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CYP7A1 SPTA1 OBSCN APOB NEB FREM2 LOXHD1 PCDH11X KCNQ2 DNAH9 HYDIN | 3.44e-10 | 184 | 185 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CYP7A1 SPTA1 OBSCN APOB NEB FREM2 LOXHD1 PCDH11X KCNQ2 DNAH9 HYDIN | 3.44e-10 | 184 | 185 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CYP7A1 SPTA1 OBSCN APOB NEB FREM2 LOXHD1 PCDH11X KCNQ2 DNAH9 HYDIN | 3.44e-10 | 184 | 185 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIF27 DSG2 SLC26A2 RPS6KA2 ZDBF2 FREM2 RBM12 PLXNA4 CCDC180 DNAH9 HYDIN | 3.64e-10 | 185 | 185 | 11 | 05bc89a566b0db90ae06506e067190a4739a0974 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | PDE1A DSG2 PAK5 DOCK10 STAP1 LOXHD1 PTPRJ ATP6V1C2 PLCG2 CLNK | 3.44e-09 | 175 | 185 | 10 | 98947a226b5a2ac7091ff9d34243ea7736add973 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-09 | 191 | 185 | 10 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-09 | 191 | 185 | 10 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.97e-09 | 191 | 185 | 10 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 8.81e-09 | 193 | 185 | 10 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ATRX NEB OGN ANGPTL1 EEF1A2 ARHGAP5 COLEC12 CCT6A ZBED6 XRN1 | 9.72e-09 | 195 | 185 | 10 | 5c86fddd6d0530beecf45ea5ba6b823123847696 |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.19e-08 | 165 | 185 | 9 | ab6ed7e30096c418e7be2d5eec33feeddd1387d9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-08 | 176 | 185 | 9 | c2c4306476989bc2fb30dab00250ef7915842f13 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-08 | 179 | 185 | 9 | 27ad6a609fe1f7532b142d0147bccf918704a6dd | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | 7.77e-08 | 183 | 185 | 9 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 | |
| ToppCell | critical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.07e-07 | 190 | 185 | 9 | 05a2c3549b68f49081723bf35db14974274419d5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-07 | 190 | 185 | 9 | bb3b396d78887d5d6f93a05c8ed4d703591bf33f | |
| ToppCell | Control-NK_CD56bright|Control / Disease condition and Cell class | 1.22e-07 | 193 | 185 | 9 | 8b1e7a226a6057e1097c1525984127b54e823876 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-07 | 195 | 185 | 9 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-07 | 197 | 185 | 9 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.66e-07 | 200 | 185 | 9 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-07 | 157 | 185 | 8 | c17c5c01fcb65c453690c265ec4f300ecdfefd34 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.04e-07 | 162 | 185 | 8 | 60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed | |
| ToppCell | E18.5-samps-Myeloid|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.04e-07 | 162 | 185 | 8 | 18e4a807e25f754a69e9eaaddfde40f8de9b8512 | |
| ToppCell | E18.5-samps-Myeloid-Macrophage|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.04e-07 | 162 | 185 | 8 | 0970e4eda60e3f015335e2726e6d565fb2f43372 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 5.83e-07 | 170 | 185 | 8 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.58e-07 | 176 | 185 | 8 | 25ebc8716aa44e44fce577701e3e82c6745a75ab | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.58e-07 | 176 | 185 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.58e-07 | 176 | 185 | 8 | 6548797336c9f4ca0f38e74a2c629e2a4defa252 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.91e-07 | 177 | 185 | 8 | 8e4005fad50e6f919da175f3b9ae58849dbd60b1 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.91e-07 | 177 | 185 | 8 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.25e-07 | 178 | 185 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.61e-07 | 179 | 185 | 8 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.36e-07 | 181 | 185 | 8 | 6aef84616e8d2faf54b7e9e6cd02f33c3066dabc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.36e-07 | 181 | 185 | 8 | 30729f0364f719c044712a51453e22dc2c1a232b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.36e-07 | 181 | 185 | 8 | 40df0afcb6848202da54670e84f22d7c3a515d01 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.36e-07 | 181 | 185 | 8 | 2b53a65ca5616a7b9f64232c3e0b7212d1e2f063 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.36e-07 | 181 | 185 | 8 | 40d3829ae4aaf81e8616c3499ff8933137fc1cc4 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-06 | 183 | 185 | 8 | 3cbe0175d05fd39bc430de1ef471ff2c5b56460e | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 1.15e-06 | 186 | 185 | 8 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-06 | 186 | 185 | 8 | c2b65b8345487710704c3eb043e9bef2e2b1ff27 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.40e-06 | 191 | 185 | 8 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 193 | 185 | 8 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 193 | 185 | 8 | 22c58032e58730715224d7934968ce92d150b0e8 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 193 | 185 | 8 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.57e-06 | 194 | 185 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-06 | 195 | 185 | 8 | f7d9adadd37209ce1a38e5d621607b9c9270fed8 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 1.77e-06 | 197 | 185 | 8 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | 1.83e-06 | 198 | 185 | 8 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 | |
| ToppCell | Control_saline-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-iNKT-MAIT|Control_saline / Treatment groups by lineage, cell group, cell type | 1.90e-06 | 199 | 185 | 8 | 2d7ebb9642f6fe0afd5e3fdc711ded54b73acd11 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.90e-06 | 199 | 185 | 8 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.90e-06 | 199 | 185 | 8 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.98e-06 | 200 | 185 | 8 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.98e-06 | 200 | 185 | 8 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.98e-06 | 200 | 185 | 8 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.98e-06 | 200 | 185 | 8 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.98e-06 | 200 | 185 | 8 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.98e-06 | 200 | 185 | 8 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.98e-06 | 200 | 185 | 8 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.18e-06 | 150 | 185 | 7 | 6c39e73a0b05d4b26589f333ce13924e3d373b8d | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.12e-06 | 156 | 185 | 7 | 5e1c5a7c9293b886920739cf766521df7f69726c | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte-neutrophil__Lgals3-negative|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.12e-06 | 156 | 185 | 7 | 166f7b1220eaf8e1149dde260dd85a094855c54f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-06 | 160 | 185 | 7 | 174a4ab27114efcc63be36929b80680be3c35c9b | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.28e-06 | 162 | 185 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.28e-06 | 162 | 185 | 7 | e17632778a57c71d6005d3abca3a0443a92040e7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-E-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.28e-06 | 162 | 185 | 7 | ac4a80fd72c9311ea2b3e574c6284bbce4f2756c | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.96e-06 | 165 | 185 | 7 | 1dcd6b8aa192baeaa1f7bb334843edab6049b96f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.96e-06 | 165 | 185 | 7 | a6c6de17fec678ad0cac3138dde3a14cc39ffd26 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.71e-06 | 168 | 185 | 7 | 063d0368d656962b335154c230bdcd9236e7c9ad | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 6.71e-06 | 168 | 185 | 7 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.71e-06 | 168 | 185 | 7 | eeb381b62c7ba263af96de1194ed59e57b6ca3ae | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.71e-06 | 168 | 185 | 7 | a7c4251d8a83bc30196a444028a35c17c24dc291 | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 7.25e-06 | 170 | 185 | 7 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.82e-06 | 172 | 185 | 7 | e72966ced5f2ee9e24ce9fd820d99a69a482a607 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.82e-06 | 172 | 185 | 7 | 83730ea3b240b8e2f2a9fb6c34dd1408050867ff | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.44e-06 | 174 | 185 | 7 | d81a5e767e8882ebca4678af881c94c062f8cea5 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.44e-06 | 174 | 185 | 7 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.44e-06 | 174 | 185 | 7 | 7c52b5d8f1e65e5208c952be341fa155ed0e6e76 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.44e-06 | 174 | 185 | 7 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Enterocyte|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.44e-06 | 174 | 185 | 7 | 2fbdb62e269acf4447b171700a615e878dde7f9f | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.44e-06 | 174 | 185 | 7 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.76e-06 | 175 | 185 | 7 | 1d8da48236549c01381f777ce5b2937f9f86acc2 | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 9.43e-06 | 177 | 185 | 7 | 43e1d0d3cf8f0c02e67d91f8dd1761df23d59e07 | |
| ToppCell | COVID-19_Mild-NK_CD56bright|COVID-19_Mild / Disease condition and Cell class | 1.01e-05 | 179 | 185 | 7 | 90e7a4af195aa2332b07a9f06cde63e72ff49255 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.05e-05 | 180 | 185 | 7 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | 1.09e-05 | 181 | 185 | 7 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.17e-05 | 183 | 185 | 7 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 184 | 185 | 7 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 184 | 185 | 7 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 184 | 185 | 7 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-05 | 184 | 185 | 7 | 92314fcdb74c0a1262c9334c774819a2a49ba454 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 186 | 185 | 7 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.30e-05 | 186 | 185 | 7 | 7950e03ea080238c168b9d807e217f459acdfb28 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-05 | 186 | 185 | 7 | bca5215d406f1785bf3a420201d5686071fcaca5 | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.35e-05 | 187 | 185 | 7 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | Myeloid-C_(Cd16+_Monocyte)|World / shred on cell class and cell subclass (v4) | 1.39e-05 | 125 | 185 | 6 | c73a77340e79f73fd1f900724e82a94d82e6b1bf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-05 | 188 | 185 | 7 | 1f912ea015f50570e848259d948a0ba682d64bb4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-05 | 188 | 185 | 7 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 1.39e-05 | 188 | 185 | 7 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| Drug | (1)-Nipecotic acid [498-95-3]; Down 200; 31uM; MCF7; HT_HG-U133A | FLOT2 IRF2BP1 ATRX SH3BP2 SRI MYOF NALF1 MIA2 ATP11B SUGP1 TRAPPC9 | 5.97e-07 | 198 | 182 | 11 | 6500_DN |
| Drug | alsterpaullone | 8.26e-06 | 35 | 182 | 5 | CID005005498 | |
| Drug | Cocaine | ZNF148 MYOM1 ATRX DSP RPS6KA3 OBSCN CAMK1G NEB SEMA4G GSK3B CCNA2 EEF1A2 JAK1 ARHGAP5 RBM12 NALF1 GUCY1B1 UBE3A KCNJ4 ATM EXOC2 SNAPC2 PLEC FRMD5 AFF4 CDH17 | 1.78e-05 | 1314 | 182 | 26 | ctd:D003042 |
| Drug | Azathymine, 6 [932-53-6]; Up 200; 31.4uM; MCF7; HT_HG-U133A | 2.74e-05 | 194 | 182 | 9 | 2827_UP | |
| Drug | Azapropazone [13539-59-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.85e-05 | 195 | 182 | 9 | 6522_DN | |
| Drug | 5151277; Up 200; 14uM; MCF7; HT_HG-U133A_EA | 2.85e-05 | 195 | 182 | 9 | 903_UP | |
| Drug | Enoxacin [74011-58-8]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 2.97e-05 | 196 | 182 | 9 | 5251_UP | |
| Drug | Pimozide [2062-78-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.97e-05 | 196 | 182 | 9 | 3178_DN | |
| Drug | SC 19220; Down 200; 10uM; MCF7; HT_HG-U133A | 3.09e-05 | 197 | 182 | 9 | 7060_DN | |
| Drug | Cyclopentolate hydrochloride [5870-29-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.09e-05 | 197 | 182 | 9 | 3555_UP | |
| Drug | Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; PC3; HG-U133A | 3.21e-05 | 198 | 182 | 9 | 1917_UP | |
| Drug | Tiletamine hydrochloride; Up 200; 15.4uM; HL60; HT_HG-U133A | 3.34e-05 | 199 | 182 | 9 | 3137_UP | |
| Drug | Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.34e-05 | 199 | 182 | 9 | 4803_DN | |
| Disease | disease of cellular proliferation (implicated_via_orthology) | 8.33e-06 | 7 | 185 | 3 | DOID:14566 (implicated_via_orthology) | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 2.01e-05 | 26 | 185 | 4 | C0009405 | |
| Disease | Bone Diseases, Developmental | 2.34e-05 | 27 | 185 | 4 | C0005941 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 2.34e-05 | 27 | 185 | 4 | C1112155 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 3.14e-05 | 29 | 185 | 4 | C1333990 | |
| Disease | factor XI measurement, venous thromboembolism | 3.61e-05 | 30 | 185 | 4 | EFO_0004286, EFO_0004694 | |
| Disease | BUDD-CHIARI SYNDROME | 3.91e-05 | 2 | 185 | 2 | 600880 | |
| Disease | Budd-Chiari Syndrome | 3.91e-05 | 2 | 185 | 2 | C0856761 | |
| Disease | Hepatic Vein Thrombosis | 3.91e-05 | 2 | 185 | 2 | C0019154 | |
| Disease | Budd-Chiari syndrome | 3.91e-05 | 2 | 185 | 2 | cv:C0856761 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 5.31e-05 | 33 | 185 | 4 | DOID:10003 (is_implicated_in) | |
| Disease | factor VIII measurement, venous thromboembolism | 5.99e-05 | 34 | 185 | 4 | EFO_0004286, EFO_0004630 | |
| Disease | fatty acid measurement | KAT5 KIF27 CYP7A1 UBE3B DARS1 APOB ESCO1 PLXNA4 SUGP1 CTNNA2 TP53BP1 | 1.04e-04 | 436 | 185 | 11 | EFO_0005110 |
| Disease | Budd-Chiari syndrome (is_implicated_in) | 1.17e-04 | 3 | 185 | 2 | DOID:11512 (is_implicated_in) | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 2.18e-04 | 19 | 185 | 3 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 2.18e-04 | 19 | 185 | 3 | C2936783 | |
| Disease | Coffin-Lowry syndrome (implicated_via_orthology) | 2.33e-04 | 4 | 185 | 2 | DOID:3783 (implicated_via_orthology) | |
| Disease | Coughing | 2.33e-04 | 4 | 185 | 2 | C0010200 | |
| Disease | cancer (implicated_via_orthology) | 3.05e-04 | 268 | 185 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | complement factor H-like 1 protein measurement | 3.42e-04 | 22 | 185 | 3 | EFO_0600092 | |
| Disease | Heart valve disease | 5.67e-04 | 26 | 185 | 3 | C0018824 | |
| Disease | Limb-girdle muscular dystrophy | 5.67e-04 | 26 | 185 | 3 | cv:C0686353 | |
| Disease | MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE | 5.77e-04 | 6 | 185 | 2 | C1854678 | |
| Disease | taurocholenate sulfate measurement | 5.77e-04 | 6 | 185 | 2 | EFO_0800277 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 6.88e-04 | 111 | 185 | 5 | EFO_0004530, EFO_0008595 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 7.08e-04 | 28 | 185 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | Arrhythmogenic right ventricular cardiomyopathy | 8.04e-04 | 7 | 185 | 2 | cv:C0349788 | |
| Disease | hereditary angioedema (is_implicated_in) | 8.04e-04 | 7 | 185 | 2 | DOID:14735 (is_implicated_in) | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 8.04e-04 | 7 | 185 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 8.04e-04 | 7 | 185 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | glycocholate measurement | 8.69e-04 | 30 | 185 | 3 | EFO_0010491 | |
| Disease | glycoprotein measurement | 9.41e-04 | 119 | 185 | 5 | EFO_0004555 | |
| Disease | apolipoprotein B measurement | PCSK5 CYP7A1 APOB ZNF112 CLASRP MYOF CSNK1G1 MYLIP SUGP1 GPSM2 PLEC HYDIN | 1.03e-03 | 663 | 185 | 12 | EFO_0004615 |
| Disease | Muscular Dystrophies, Limb-Girdle | 1.05e-03 | 32 | 185 | 3 | C0686353 | |
| Disease | Huntington's disease (implicated_via_orthology) | 1.05e-03 | 32 | 185 | 3 | DOID:12858 (implicated_via_orthology) | |
| Disease | Nemaline myopathy | 1.07e-03 | 8 | 185 | 2 | cv:C0206157 | |
| Disease | atypical hemolytic-uremic syndrome (is_implicated_in) | 1.07e-03 | 8 | 185 | 2 | DOID:0080301 (is_implicated_in) | |
| Disease | Polycythemia Vera | 1.07e-03 | 8 | 185 | 2 | C0032463 | |
| Disease | Malignant neoplasm of breast | CFL1 CFL2 RPS6KA3 OBSCN COLGALT2 DYSF PKDREJ CHRND CLASRP PBRM1 MIA2 SLC6A5 ASTN2 ATM DNAH9 TP53BP1 | 1.26e-03 | 1074 | 185 | 16 | C0006142 |
| Disease | Nonsyndromic genetic hearing loss | 1.35e-03 | 76 | 185 | 4 | cv:C5680182 | |
| Disease | Lynch Syndrome | 1.37e-03 | 9 | 185 | 2 | C4552100 | |
| Disease | Atypical hemolytic-uremic syndrome | 1.37e-03 | 9 | 185 | 2 | cv:C2931788 | |
| Disease | Hemolytic-uremic syndrome | 1.37e-03 | 9 | 185 | 2 | cv:C0019061 | |
| Disease | endometrial cancer (is_implicated_in) | 1.49e-03 | 36 | 185 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | macrovascular complications of diabetes | 1.70e-03 | 10 | 185 | 2 | EFO_0010977 | |
| Disease | Atypical Hemolytic Uremic Syndrome | 1.70e-03 | 10 | 185 | 2 | C2931788 | |
| Disease | level of Ceramide (d42:1) in blood serum | 1.70e-03 | 10 | 185 | 2 | OBA_2045187 | |
| Disease | venous thromboembolism, factor VII measurement | 1.74e-03 | 38 | 185 | 3 | EFO_0004286, EFO_0004619 | |
| Disease | aspartate aminotransferase measurement | KIF27 MYO7A SLC26A2 CFL2 OBSCN CFHR3 TMX2 SETDB1 PTPRJ SUGP1 ASTN2 CTNNA2 ABCC2 HEPHL1 | 1.77e-03 | 904 | 185 | 14 | EFO_0004736 |
| Disease | Epilepsy, Cryptogenic | 1.79e-03 | 82 | 185 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 1.79e-03 | 82 | 185 | 4 | C0751111 | |
| Disease | Aura | 1.79e-03 | 82 | 185 | 4 | C0236018 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.87e-03 | 139 | 185 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | colon cancer (biomarker_via_orthology) | 1.88e-03 | 39 | 185 | 3 | DOID:219 (biomarker_via_orthology) | |
| Disease | Hypercholesterolemia | 1.88e-03 | 39 | 185 | 3 | C0020443 | |
| Disease | non-high density lipoprotein cholesterol measurement | PCSK5 CYP7A1 CFL2 SPTA1 RPS6KA3 APOB ERGIC2 PBRM1 MYLIP XRN1 SUGP1 HYDIN | 1.90e-03 | 713 | 185 | 12 | EFO_0005689 |
| Disease | bipolar I disorder | 2.00e-03 | 141 | 185 | 5 | EFO_0009963 | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 2.02e-03 | 40 | 185 | 3 | EFO_0004746 | |
| Disease | Intellectual Disability | 2.14e-03 | 447 | 185 | 9 | C3714756 | |
| Disease | Tumoral calcinosis | 2.33e-03 | 42 | 185 | 3 | C0263628 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 2.33e-03 | 42 | 185 | 3 | EFO_0004286, EFO_0004629 | |
| Disease | Calcinosis | 2.33e-03 | 42 | 185 | 3 | C0006663 | |
| Disease | Microcalcification | 2.33e-03 | 42 | 185 | 3 | C0521174 | |
| Disease | level of Ceramide (d42:2) in blood serum | 2.48e-03 | 12 | 185 | 2 | OBA_2045186 | |
| Disease | Thromboembolism | 2.48e-03 | 12 | 185 | 2 | C0040038 | |
| Disease | triglycerides in large LDL measurement | 2.49e-03 | 43 | 185 | 3 | EFO_0022319 | |
| Disease | Neoplasm Metastasis | 2.55e-03 | 217 | 185 | 6 | C0027627 | |
| Disease | saturated fatty acids measurement | 2.84e-03 | 45 | 185 | 3 | EFO_0022304 | |
| Disease | hematologic cancer (implicated_via_orthology) | 2.91e-03 | 13 | 185 | 2 | DOID:2531 (implicated_via_orthology) | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 2.91e-03 | 13 | 185 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.98e-03 | 224 | 185 | 6 | EFO_0004574, EFO_0008317 | |
| Disease | heart rate variability measurement, response to antipsychotic drug | 3.02e-03 | 46 | 185 | 3 | EFO_0008003, GO_0097332 | |
| Disease | Adenocarcinoma of large intestine | 3.17e-03 | 96 | 185 | 4 | C1319315 | |
| Disease | Autosomal recessive limb-girdle muscular dystrophy | 3.39e-03 | 14 | 185 | 2 | cv:C2931907 | |
| Disease | GDH/6PGL endoplasmic bifunctional protein measurement | 3.39e-03 | 14 | 185 | 2 | EFO_0801619 | |
| Disease | hearing impairment | 3.42e-03 | 98 | 185 | 4 | C1384666 | |
| Disease | status epilepticus (biomarker_via_orthology) | 3.67e-03 | 100 | 185 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | Alzheimer disease | 3.67e-03 | 485 | 185 | 9 | MONDO_0004975 | |
| Disease | Acute kidney injury | 3.81e-03 | 101 | 185 | 4 | C2609414 | |
| Disease | Psychotic Disorders | 3.81e-03 | 101 | 185 | 4 | C0033975 | |
| Disease | Acute Kidney Insufficiency | 3.81e-03 | 101 | 185 | 4 | C1565662 | |
| Disease | Kidney Failure, Acute | 3.81e-03 | 101 | 185 | 4 | C0022660 | |
| Disease | platelet measurement | 3.86e-03 | 315 | 185 | 7 | EFO_0005036 | |
| Disease | low density lipoprotein triglyceride measurement | 3.89e-03 | 15 | 185 | 2 | EFO_0009946 | |
| Disease | schizophrenia (biomarker_via_orthology) | 3.89e-03 | 15 | 185 | 2 | DOID:5419 (biomarker_via_orthology) | |
| Disease | response to statin, LDL cholesterol change measurement | 3.89e-03 | 15 | 185 | 2 | EFO_0007804, GO_0036273 | |
| Disease | thrombosis (is_implicated_in) | 3.89e-03 | 15 | 185 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | amenorrhea, response to antineoplastic agent | 3.89e-03 | 15 | 185 | 2 | EFO_0010269, GO_0097327 | |
| Disease | Schizophrenia | GPS1 LCN2 IL18R1 GSK3B CCNA2 SETDB1 PTPN6 PBRM1 SLC6A5 KCNQ2 ASTN2 ATM CTNNA2 | 3.93e-03 | 883 | 185 | 13 | C0036341 |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 4.05e-03 | 51 | 185 | 3 | cv:CN043650 | |
| Disease | phospholipids in very small VLDL measurement | 4.05e-03 | 51 | 185 | 3 | EFO_0022300 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 4.43e-03 | 16 | 185 | 2 | C0334634 | |
| Disease | Abnormal behavior | 4.43e-03 | 16 | 185 | 2 | C0233514 | |
| Disease | sickle cell anemia (is_implicated_in) | 4.43e-03 | 16 | 185 | 2 | DOID:10923 (is_implicated_in) | |
| Disease | triglycerides in HDL measurement | 4.51e-03 | 53 | 185 | 3 | EFO_0022317 | |
| Disease | triglycerides in medium HDL measurement | 4.76e-03 | 54 | 185 | 3 | EFO_0022321 | |
| Disease | melanoma | 4.89e-03 | 248 | 185 | 6 | C0025202 | |
| Disease | Epilepsy | 4.99e-03 | 109 | 185 | 4 | C0014544 | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 5.00e-03 | 17 | 185 | 2 | C1839839 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 5.00e-03 | 17 | 185 | 2 | C0751883 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YEYTLGEEKFTFIEK | 351 | P40227 | |
| DVAYYFEKDVKGESL | 211 | P16422 | |
| LGYISKAEEYFLLKS | 381 | Q07001 | |
| YSKFDVINLAAEKTY | 241 | P54619 | |
| EGYYQKLSKAFVELT | 181 | O95394 | |
| RYALYDATYETKESK | 81 | P23528 | |
| FTLDVYRYKDSLKED | 56 | Q9NP73 | |
| KYFTEAGLKELSEYV | 231 | Q7L1Q6 | |
| KYEYEVDKDFSSKLR | 61 | Q96RQ1 | |
| DVYDKVDYLSSLGKT | 156 | Q14254 | |
| KDSKFYLEGEVLFVS | 516 | P78314 | |
| LKVAILAEKYAVDYS | 426 | O95782 | |
| DRYISKYELDKAFSD | 1426 | P01024 | |
| DKKVYAEYSSFRLEP | 376 | O95841 | |
| LAIAYRDLDDKYFKE | 596 | Q8TF62 | |
| FVYSKSDALLSKDRY | 1146 | Q8TDJ6 | |
| EARDAVYLKYLASFE | 1651 | Q9P1Z9 | |
| VYLKYLASFEEELKR | 1656 | Q9P1Z9 | |
| KKVDEYTDTDLYTGE | 1106 | O75129 | |
| SYLEKVVAIYDYTKD | 451 | Q9NYB9 | |
| ALSDRFEKAVYYLDA | 931 | Q9UHB7 | |
| SYLYFEEKDFVDKAE | 516 | Q9UBL3 | |
| EDFIYKHRKALESEY | 2196 | Q6ZS30 | |
| KKLDIVEDSIYIAYG | 451 | Q9NTZ6 | |
| DFGLTKAIETDKEYY | 1021 | P23458 | |
| GVVLYELFTYIEKSK | 1041 | O60674 | |
| AKEGTKADLEVLTYY | 716 | Q14571 | |
| FLDYAYTGKTKITDD | 106 | Q8NAB2 | |
| VVFEEKSHYKVDYSR | 321 | P48050 | |
| DLAEERGLKITYKYT | 76 | Q14126 | |
| YTTEKYREKSLYGDD | 141 | Q9P286 | |
| YADKEETKLKGVIYF | 566 | Q6NSJ2 | |
| VLKYTYEDFKKGASD | 866 | Q12913 | |
| FYAKELTTYEIEEFK | 171 | Q5TC84 | |
| RFSLSAKVVDDEIYY | 1276 | Q86U86 | |
| DGKTYDAFVSYLKEC | 371 | Q13478 | |
| GEFETASEYYKKTLL | 256 | P81274 | |
| LSKKEDVFAYLAKYS | 136 | Q86YW9 | |
| KDAVTEKKYILYDFS | 811 | Q2M2H8 | |
| SGEIISDYKYKEAFE | 1056 | Q86VF7 | |
| IFYKLLADGYSEKIE | 3281 | Q03001 | |
| VLTEAGDYTEKYLKL | 371 | Q8NCI6 | |
| EEDDSKEYGEFYKSL | 236 | Q58FF7 | |
| IITLKDVYDDGKYVY | 476 | P51812 | |
| YLRTLFTDLFEKKGY | 306 | Q9HCP0 | |
| ISFEKEYYLVNEDSK | 1771 | Q5SZK8 | |
| IVGYFSKEKESTEDY | 351 | Q92993 | |
| YGKLLIEFSYELSKV | 381 | Q92993 | |
| DSRVYIKLYGDKSDT | 701 | Q8IVV2 | |
| RYALYDATYETKESK | 81 | Q9Y281 | |
| LEKDLYFYKKTSRDH | 1206 | Q86VH2 | |
| TVYRKFKYGLLDDDD | 1831 | Q92824 | |
| SEIFSYVGKYSEEIL | 1851 | Q9HCM2 | |
| FKKYYAEVETRIEAL | 321 | Q96KP1 | |
| KEYEKSSEGALYILE | 116 | O43526 | |
| ISFKYKEFELSGYIS | 226 | Q9UHC1 | |
| ITFAEALEVGYSKYK | 201 | P54750 | |
| DKCYYFSVEKEIFED | 616 | Q5KU26 | |
| VRDIIFKFYESKYAS | 326 | Q13098 | |
| SDIESVERKIYKAYK | 651 | Q96JK2 | |
| YVFDIKRTSKEVYDH | 311 | Q8WY64 | |
| SIFSQDYEDKYLDGK | 41 | P20774 | |
| YDFYTSIFDKIREKE | 736 | Q96RT8 | |
| FIETGKVKFSIYLEY | 956 | Q92887 | |
| IIYDDSKTYDLVAAA | 41 | Q02153 | |
| KILLKYGERESSYVF | 436 | Q96MN2 | |
| ALYDYKAKRSDELSF | 776 | P16885 | |
| AAYLDYESTKEYAIK | 421 | Q9BZA7 | |
| FDREKQESYTFYVKA | 631 | Q9BZA7 | |
| AVDKEYEFEVHEKTY | 521 | O95672 | |
| KLFEKIKEGYYEFES | 226 | Q96NX5 | |
| VSTAIQEFYKKYAEE | 5796 | Q5VST9 | |
| EYFKITLYGRTKELT | 151 | P80188 | |
| KSKEYDRLYEEYTRT | 191 | Q92569 | |
| TAYETLKDEETRKDY | 106 | Q9H1X3 | |
| FEGKTFYLYVSQKEE | 251 | Q7Z6J6 | |
| EAYEVLSDAKKRDIY | 51 | O75190 | |
| STFYESLKYARVKEV | 2141 | Q13315 | |
| LSDYYEKFIAESKRL | 4506 | P04114 | |
| LDYISKENKGYFDED | 1891 | P46100 | |
| SDRKYYAKTGDTIEF | 286 | Q02985 | |
| EVSRLSDYEIESKYK | 236 | B1AJZ9 | |
| LDYIDVLSGSKKDYK | 4781 | Q4G0P3 | |
| YESKYGEVSKTLDLL | 396 | Q8NA47 | |
| EKQRDFKKLSDLYYD | 1841 | Q96BY6 | |
| KKEYEQEFDFIKSYS | 211 | A0AVK6 | |
| LKETLYETIIGYFDK | 1276 | Q92608 | |
| YEAGVYTEKVLEATK | 561 | P26232 | |
| YKDLRKFLESKGYEF | 126 | O94808 | |
| TKDTDIVDEAIYYFK | 36 | O15145 | |
| EAYEVLSDAKKRDIY | 51 | Q8WWF6 | |
| EAYEVLSDKHKREIY | 51 | P25686 | |
| AYSEKRYDEIVKEVS | 161 | Q05639 | |
| TFGYEELKDKETNYF | 411 | Q96PZ2 | |
| YYDKAFDRITTRSEK | 201 | O15371 | |
| EAYKKGLIDYETFKE | 2481 | P15924 | |
| DKIERFKKAVEYYSV | 391 | Q9NX05 | |
| LYDDAAIFEAKKSFY | 441 | Q14534 | |
| FYSSGEKKDEVYLNL | 116 | P49841 | |
| ALALEYYKQGKTEEF | 46 | Q6PD62 | |
| TGIYSKTSDDEVFKY | 276 | O75976 | |
| KTSDDEVFKYLAKAY | 281 | O75976 | |
| KYFETDDPEFYKSKV | 596 | O15033 | |
| KDLYELAFSISYDRG | 621 | Q96BJ8 | |
| SFLFKIDKSYREDVY | 1011 | Q6MZM0 | |
| EDAEYYFQKEFSKEL | 351 | P09913 | |
| LAAYYLSGEEIFKIK | 276 | O60476 | |
| TLYYAKTAKSIIFDE | 81 | Q16760 | |
| VGSDTFYSFKYEIKE | 66 | P01042 | |
| TFKYDRYLDENGKTK | 406 | P22680 | |
| IYGSYLSKEEIAFSD | 796 | Q5FWF5 | |
| TIFDYYIDPETKKFE | 2416 | Q9NYC9 | |
| EYESRSYTLEFIGKK | 2136 | Q8NDH2 | |
| LKKGTYDKAYTDELV | 486 | Q03111 | |
| KAITHYYIETSDDKA | 31 | Q5W0V3 | |
| ADFNKTELERYKELY | 1266 | A2RUR9 | |
| AEFVYITDDTYTKKQ | 276 | P20248 | |
| FLSRYKDEAQLYKEE | 461 | O60645 | |
| AEYKEYYESRDLKAF | 536 | Q8IYK4 | |
| EEKDAYVFYAVAKDE | 301 | Q12864 | |
| LSDKFRKEYYALGSL | 451 | Q9P1V8 | |
| CGSYLEKDFDTLKVY | 1491 | O75923 | |
| EKEKDEDGFLYVAYS | 96 | P60520 | |
| KALASSGFKYLEYER | 306 | Q8IU81 | |
| YGKFAEKYDSDRTEL | 481 | Q14554 | |
| LEKFSLVQKEYEGYE | 701 | Q96PC5 | |
| IYYFSSAEAKEKFLE | 961 | Q5TCS8 | |
| KENKFTVREFYYDEK | 241 | Q8NEY4 | |
| NKTYTAYVDLEKDFA | 286 | P54577 | |
| RYIVLAKDFEKAYKT | 391 | P43686 | |
| SEEYFKYFVLKISAG | 371 | Q9Y345 | |
| LSVTSFKKIVYREYE | 56 | P12259 | |
| EDTTYKKVVFRKYLD | 1611 | P12259 | |
| EVALSYYKKVADYIA | 236 | Q5TEA6 | |
| KKEFDFAAAYSYLDT | 216 | Q0VDG4 | |
| DFDRKASAEIYLYVA | 1956 | Q9NTG1 | |
| DDEATRKAYYKEFRK | 116 | Q9NVN8 | |
| ELHYTKEKLGEEAAY | 96 | Q9Y6C5 | |
| YYTSVEIYGLDSVKK | 216 | Q8NEA9 | |
| LFGYLTFYDKVESEL | 301 | Q8IZM9 | |
| TFYDKVESELLKGYS | 306 | Q8IZM9 | |
| YKSSLKDFRYGVEDF | 166 | Q07837 | |
| LGHLVKEKYDTDFYI | 376 | P14868 | |
| EAYKYITEADSKEVY | 461 | Q13017 | |
| DTIFKQKGYSDEIYV | 1096 | Q13017 | |
| DSIKYKYFLELGRID | 326 | Q8TC41 | |
| SYKTEFDFSDYVKRK | 201 | P20701 | |
| QEFKVELEKSGYYTL | 1956 | Q9ULL5 | |
| TSKITYFKRKYVEEE | 71 | Q9NUC0 | |
| VKDFYSKLGLQYRDS | 96 | Q15047 | |
| IKESEYADTHYFKVA | 91 | Q7Z7G1 | |
| LAEKKASIGYTYEDS | 156 | Q8N2M8 | |
| AYRKFTSKEYEEIDK | 631 | Q9Y2G3 | |
| DYSEYKEFKLTVENI | 551 | Q8IWZ8 | |
| YFSVDSFDIVKYELE | 61 | Q96JG6 | |
| EYIKYFNDKTIDEEL | 136 | Q9Y320 | |
| DFKESLKVVFEGSAY | 31 | O75762 | |
| DFKDVTYLTEEKVYE | 121 | Q05086 | |
| EFLFTLYSAGEEKEK | 66 | A0A0B4J274 | |
| ESKASAVGDDDKVYY | 226 | Q9NTN9 | |
| KKEEENLLFYSVYEA | 701 | P50443 | |
| AEEYRLKEHYLTFEK | 691 | Q9BQI7 | |
| FYTDKKSIIYVDKLD | 56 | Q9ULZ2 | |
| LYGVDDKFYSKLDQE | 56 | Q99426 | |
| EYIDYEFSVLKEKIT | 256 | Q8IZH2 | |
| IYLEDKSYKLGDFDV | 1396 | Q9HCK1 | |
| YEQRLEFGFDKYSSK | 541 | Q6UXI7 | |
| FLFLAYKVSKTDREY | 86 | Q9UGP8 | |
| KGYVSLEDYTAFLID | 2331 | P02549 | |
| HRKESGELYYSIEKE | 1561 | Q12888 | |
| GIYLEDTKEKVSIYE | 3496 | Q15149 | |
| GEKFATLTELVEYYT | 66 | P29350 | |
| EEKLYTDIEYGKSFI | 411 | Q9UJU3 | |
| FYKNLTSIKRYDGDI | 826 | Q7Z3V4 | |
| VVDEYFKEKYSEFSG | 866 | P86452 | |
| KIAYTYSVSFEEDDK | 266 | Q99805 | |
| KRLGFFQTYDTEYLK | 736 | O95789 | |
| YAGICTEYEKDFSLK | 301 | Q5JVG2 | |
| EDIIDKYKEAISYYS | 321 | Q96Q05 | |
| TYEESKVSKYAFELV | 416 | Q9UQR1 | |
| FRKDDFYYLSQEDKE | 556 | Q9HBM0 | |
| DFAVDFEKIYKYLSS | 201 | Q13487 | |
| KRYSTNGKITFDDYI | 146 | P30626 | |
| YIALDDFVEITKKYA | 241 | O76024 | |
| TLKDVYDDGKFVYLV | 471 | Q15349 | |
| KLRTFSDIDKYYTEQ | 416 | A6PVS8 | |
| QEKYEEFESVLHKYL | 276 | B1AL88 | |
| IYRVKFEEDKSYFPS | 2041 | Q13402 | |
| DGKSIRYKDLYALFE | 1916 | B2RTY4 | |
| KDLKISVYDYDTFTR | 1616 | Q9NZM1 | |
| ESKDAKELVGYYIEA | 761 | P52179 | |
| EYRKDYEKSKTIYTA | 881 | P20929 | |
| KASRDVISDYKYKDG | 3026 | P20929 | |
| YVGDITSDIKYKEDL | 5081 | P20929 | |
| YKEVFERTKSDFKYV | 5371 | P20929 |